DeutschNewstral
Sanofi SNY
- MThere's an ETF sending one market haywire. A hedge-fund pro says bitcoin-like gains may come next.3 min readmarketwatch.com
- MSanofi teams up with BioNTech and Pfizer to help fix Europe's vaccine shortagemarketwatch.com
- MEuropean stocks struggle and Nasdaq futures are higher with investors focused on Fed and big tech earningsmarketwatch.com
- MInitial data from a pair of clinical trials may revive interest in arthritis drugs as COVID-19 treatmentsmarketwatch.com
- MRegeneron shares gain as the company launches Phase 3 trial for COVID-19 antibody treatmentmarketwatch.com
- MRegeneron to expand development deal with Intellia Therapeuticsmarketwatch.com
- MSanofi says it's considering IPO of pharmaceutical-ingredients armmarketwatch.com
- MFacing criticism over insulin prices, drugmakers offer more affordable optionsmarketwatch.com
- MSanofi recalls Zantac because of possible contamination with potentially cancer-causing NDMAmarketwatch.com
- MRegeneron stock up 2.2% after earnings beatmarketwatch.com
- MLexicon's stock loses more than half its value after Sanofi's notice to end alliancemarketwatch.com
- MBernie Sanders is riding in a caravan to Canada with diabetics to get more affordable insulinmarketwatch.com
- MCummings, Grassley vow to combat rising drug prices in dueling hearingsmarketwatch.com
- MSanofi, Regeneron have skin-cancer drug approvedmarketwatch.com
- MAmbien maker responds to Roseanne: Racism is ‘not a known side effect’marketwatch.com
- MEsperion shares halted on late-stage trial resultsmarketwatch.com
- MEsperion shares plummet 20% on late-stage trial resultsmarketwatch.com
- MRegeneron discounts on cholesterol drug sends some rival stocks downmarketwatch.com
- MRegeneron stock lifts 4% after Q4 profit, revenue beatsmarketwatch.com
- MThe next phase of artificial intelligence will replace inventorsmarketwatch.com
Frequent names
Newstral's extraction of names of people and organisations from the world's news is completely automated. If you do not want your name to appear here, please contact us. We will be happy to look at your request.